-transparent.png){kind=logo}
Endothelin, a potent vasoconstrictor, was found to be ineffective in the treatment of experimentally induced corneal neovascularization. Endothelin was administered topically, subconjunctivally, and intraluminally in serial concentrations ranging from 0.0005 to 5.0 micrograms/mL in New Zealand white rabbits without effect. Electron microscopy of the neovascular cornea revealed the vessels consisted only of endothelin and pericytes. Hence, the vessels were not responsive to endothelin because they lacked contractile smooth muscle.
Related Publications
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
June 2020,
Attention, perception & psychophysics,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
January 2007,
Reproduction (Cambridge, England),
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
November 1990,
Clinical physiology (Oxford, England),
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
January 1987,
Vision research,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
June 2003,
Fertility and sterility,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
November 2018,
Molecular medicine reports,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
February 2008,
Experimental eye research,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
October 2014,
Motor control,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
January 2019,
Journal of pain research,
R A Eiferman, and
J Stagner, and
M Jumblatt, and
K P O'Neill, and
D A Smith
June 2019,
Current eye research,
